UCB - Daily - Technical analysis published on 03/13/2024 (GMT)
- 102
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
67%
6%
28%
My opinion
Bullish above 104.45 EUR
My targets
112.77 EUR (+4.42%)
My analysis
The bullish trend is currently very strong on UCB. As long as the price remains above the support at 104.45 EUR, you could try to benefit from the boom. The first bullish objective is located at 112.77 EUR. The bullish momentum would be boosted by a break in this resistance. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
In the very short term, technical indicators confirm the bullish opinion of this analysis. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The UCB price is 108.00 EUR. On the day, this instrument lost -0.14% with the lowest point at 107.70 EUR and the highest point at 108.60 EUR. The deviation from the price is +0.28% for the low point and -0.55% for the high point.107.70
108.60
108.00
A bullish opening was detected by the Central Gaps scanner. Buyers are trying to impose a bullish momentum in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by UCB:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of UCB in Daily shows a strongly overall bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
In fact, according to the parameters integrated into the Central Analyzer system, 12 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 70
Type : Neutral
Timeframe : Daily
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near resistance of channel
Type : Bearish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
Price
S3 | S2 | S1 | Price | R1 | R2 | |
---|---|---|---|---|---|---|
ProTrendLines | 87.30 | 97.11 | 104.45 | 108.00 | 108.39 | 112.77 |
Change (%) | -19.17% | -10.08% | -3.29% | - | +0.36% | +4.42% |
Change | -20.70 | -10.89 | -3.55 | - | +0.39 | +4.77 |
Level | Intermediate | Intermediate | Minor | - | Intermediate | Major |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 104.65 | 105.65 | 106.90 | 107.90 | 109.15 | 110.15 | 111.40 |
Camarilla | 107.53 | 107.74 | 107.94 | 108.15 | 108.36 | 108.56 | 108.77 |
Woodie | 104.78 | 105.71 | 107.03 | 107.96 | 109.28 | 110.21 | 111.53 |
Fibonacci | 105.65 | 106.51 | 107.04 | 107.90 | 108.76 | 109.29 | 110.15 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 103.47 | 104.83 | 107.37 | 108.73 | 111.27 | 112.63 | 115.17 |
Camarilla | 108.83 | 109.19 | 109.54 | 109.90 | 110.26 | 110.62 | 110.97 |
Woodie | 104.05 | 105.13 | 107.95 | 109.03 | 111.85 | 112.93 | 115.75 |
Fibonacci | 104.83 | 106.32 | 107.24 | 108.73 | 110.22 | 111.14 | 112.63 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 71.33 | 78.55 | 92.52 | 99.74 | 113.71 | 120.93 | 134.90 |
Camarilla | 100.67 | 102.62 | 104.56 | 106.50 | 108.44 | 110.39 | 112.33 |
Woodie | 74.72 | 80.24 | 95.91 | 101.43 | 117.10 | 122.62 | 138.29 |
Fibonacci | 78.55 | 86.64 | 91.64 | 99.74 | 107.83 | 112.83 | 120.93 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
RSI (14): | 74.91 | |
MACD (12,26,9): | 5.1900 | |
Directional Movement: | 25.18 | |
AROON (14): | 85.71 | |
DEMA (21): | 109.96 | |
Parabolic SAR (0,02-0,02-0,2): | 101.39 | |
Elder Ray (13): | 2.38 | |
Super Trend (3,10): | 102.80 | |
Zig ZAG (10): | 108.05 | |
VORTEX (21): | 1.3300 | |
Stochastique (14,3,5): | 88.10 | |
TEMA (21): | 111.19 | |
Williams %R (14): | -13.63 | |
Chande Momentum Oscillator (20): | 11.46 | |
Repulse (5,40,3): | 0.8100 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.8000 | |
Courbe Coppock: | 27.80 |
MA7: | 108.61 | |
MA20: | 102.40 | |
MA50: | 92.56 | |
MA100: | 82.19 | |
MAexp7: | 107.91 | |
MAexp20: | 103.08 | |
MAexp50: | 94.59 | |
MAexp100: | 88.05 | |
Price / MA7: | -0.56% | |
Price / MA20: | +5.47% | |
Price / MA50: | +16.68% | |
Price / MA100: | +31.40% | |
Price / MAexp7: | +0.08% | |
Price / MAexp20: | +4.77% | |
Price / MAexp50: | +14.18% | |
Price / MAexp100: | +22.66% |
Quotes :
-
15 min delayed data
-
Euronext Bruxelles
News
Don't forget to follow the news on UCB. At the time of publication of this analysis, the latest news was as follows:
- First Presentation of Year 4 BIMZELX® (bimekizumab-bkzx) Data Showed Long-Term Maintenance of Complete Skin Clearance in Moderate-to-Severe Plaque Psoriasis
- BIMZELX® 48-Week Phase 3 Analyses in Moderate-to-Severe Hidradenitis Suppurativa Showed Sustained Improvements in Skin Pain and Draining Tunnel Count
- UCB on Growth Path for a Decade Plus
- ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S. for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients Who Are Anti-Acetylcholine Receptor (AChR) Antibody Positive
- UCB presents new data about the real-world experience of FINTEPLA® (fenfluramine) and rare epilepsy syndromes at 2023 American Epilepsy Society (AES) Annual Meeting
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis UCB - Daily